Exploring molecular mechanisms and genetic dysregulation in aging and age-associated diseases

FHS
August 10, 2023
12:12 pm

Researchers review existing data on the molecular basis of senescence and neurodegeneration in age-related brain diseases.

Bristol Myers bets on neuroscience surge with $14B Karuna cash acquisition

Bristol Myers Squibb will buy CNS drugmaker Karuna Therapeutics for cash in a deal valued at $14 billion, the companies announced Friday morning. The move

December 23, 2023

Janssen looks to turn PhIII win for Rybrevant in EGFR-mutated NSCLC into pressure on AstraZeneca blockbuster

Johnson & Johnson’s Janssen said Wednesday that its bispecific antibody Rybrevant (amivantamab-vmjw) in combo with lazertinib met its dual primary endpoints in a Phase III

September 7, 2023

Penn State researchers receive $3 million grant to develop new revascularization techniques

The ability to regenerate and pattern blood vessels, the literal lifelines extending deep into soft tissues, remains an elusive milestone in regenerative medicine.

July 7, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.